Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 6712
TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149386(US8975247, EBP661)
Affinity DataIC50: 260nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149384(US8975247, EBP660)
Affinity DataIC50: 490nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149382(US8975247, EBP881)
Affinity DataIC50: 580nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149400(US8975247, EBP425)
Affinity DataIC50: 650nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149378(US8975247, EBP470)
Affinity DataIC50: 980nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149396(US8975247, EBP163)
Affinity DataIC50: 1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149388(US8975247, EBP315)
Affinity DataIC50: 1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM85747(CLEMIZOLE HYDROCHLORIDE | NSC_2782 | CAS_442-52-4 ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149377(US8975247, EBP933)
Affinity DataIC50: 1.10E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149380(US8975247, EBP467)
Affinity DataIC50: 1.10E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149395(US8975247, EBP271)
Affinity DataIC50: 1.30E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149379(US8975247, EBP372)
Affinity DataIC50: 1.60E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149392(US8975247, EBP101)
Affinity DataIC50: 4.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149381(US8975247, EBP882)
Affinity DataIC50: 4.30E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149391(US8975247, EBP106)
Affinity DataIC50: 5.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149398(US8975247, EBP484)
Affinity DataIC50: 5.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM50447261(CHEMBL1945694)
Affinity DataIC50: 7.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149393(US8975247, EBP144)
Affinity DataIC50: 7.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149383(US8975247, EBP461)
Affinity DataIC50: 8.80E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149390(US8975247, EBP325)
Affinity DataIC50: 1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149389(US8975247, EBP462)
Affinity DataIC50: 1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149387(US8975247, EBP475)
Affinity DataIC50: 1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149385(US8975247, EBP468)
Affinity DataIC50: 1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149397(US8975247, EBP376)
Affinity DataIC50: 1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM61806(N-[1-(4-methoxybenzyl)-5,6-dimethyl-1H-1,3-benzimi...)
Affinity DataIC50: 3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149394(US8975247, EBP108)
Affinity DataIC50: 3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
The Board of Trustees of The Leland Stanford Junion University

US Patent
LigandPNGBDBM149399(US8975247, EBP143)
Affinity DataIC50: 3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
In DepthDetails
US Patent